An Experimental Design Approach for Producing Curcumin-Loaded Solid Lipid Nanoparticles

Area of Science:

• Nanotechnology
• Pharmaceutical Sciences
• Drug Delivery

Background:

• Curcumin possesses significant antioxidant, anti-inflammatory, and anticancer properties.
• Low bioavailability of curcumin limits its clinical use due to poor solubility and rapid metabolism.
• Developing effective delivery systems is crucial for harnessing curcumin's therapeutic potential.

Purpose of the Study:

• To enhance curcumin's solubility and bioavailability using self-nanoemulsifying drug delivery systems (SLNs).
• To optimize SLN formulations by investigating the synergistic effects of Brij and Gelucire 48/16.
• To evaluate the physicochemical properties, cellular uptake, and anticancer efficacy of curcumin-loaded SLNs.

Main Methods:

• Investigated curcumin saturation solubility and formulated SLNs using various ingredients.
• Employed experimental design to optimize SLN formulation with Brij and Gelucire 48/16.
• Characterized SLNs for particle size, zeta potential, morphology, encapsulation efficiency, drug loading, and in vitro release. Evaluated cell viability and internalization.

Main Results:

• A combination of Brij and Gelucire 48/16 significantly increased curcumin's aqueous solubility by 452.5-fold.
• Successfully produced spherical curcumin-loaded SLNs with a particle size of 389.3 nm and high encapsulation efficiency.
• Curcumin-loaded SLNs demonstrated enhanced cellular internalization and improved anticancer activity against lung cancer cells.

Conclusions:

• Surfactant quantity, particularly the 3:1 Brij-Gelucire 48/16 ratio, is critical for optimizing drug loading efficiency.
• SLNs effectively improve curcumin's cellular uptake and anticancer efficacy.
• This lipid-based colloidal system shows promise for advanced drug delivery applications.